Clinical Trials Browser

Phase 2/3 × INDUSTRY × Carcinoma in Situ × Clear all

NCT01438112 2021-04-14

BOND

Phase 2/3 Terminated

Adenoviridae Infections, Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell, Neoplasms, Virus Diseases

NCT00406068 2016-07-28

Mycobacterial Cell Wall-DNA Complex in Treatment of BCG-refractory Patients With Non-muscle Invasive Bladder Cancer

Phase 2/3 Completed

Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell, Mycobacterium Infections, Neoplasm Recurrence, Local

NCT01316874 2015-06-12

Bladder Cancer

Phase 2/3 Completed

Urinary Bladder Neoplasms, Carcinoma in Situ